Higher LN metastasis and TB, CXCR4, 5β-integrin, VEGFA, and Serpine-1 overexpression in KRAS G12V than KRAS G13D CRC, supporting the higher aggressiveness of CRC harboring this specific mutation. This evidence concerns the gene KRAS and colorectal carcinoma.